Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

News

  • Home
  •  
  • News



  • Most Read
  • Latest Comments
  • Lumos Diagnostics partners with Apatek to create rare disorder test for newborns
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Lumos Diagnostics partners with Apatek to create rare disorder test for newborns
    • News

    Smart pain assessment app now used by more than half of Australia’s residential aged care providers
    Public
  • Lumos Diagnostics partners with Apatek to create rare disorder test for newborns
    • News

    Fledgling fintech hopes millennials put their Douugh into micro-investing ‘super’ app
    Public
  • Lumos Diagnostics partners with Apatek to create rare disorder test for newborns
    • News

    🎵 The knee bone’s connected to the… collagen rope device (?!)
    Public
  • Lumos Diagnostics partners with Apatek to create rare disorder test for newborns
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial
    • Review
    • September 1, 2022

Latest Articles

  • PainChek locks in performance data for FDA submission, aiming to be  first pain assessment app approved in US
    PainChek locks in performance data for FDA submission, aiming to be first pain assessment app approved in US
    • News

  • HeraMED eyes TGA reclassification to restore HeraBEAT device for at-home use
    HeraMED eyes TGA reclassification to restore HeraBEAT device for at-home use
    • News

  • dorsaVi secures $110k in contracts across mining, healthcare, and shipping sectors
    dorsaVi secures $110k in contracts across mining, healthcare, and shipping sectors
    • News

  • Compumedic hits record medtech diagnostics revenue with growth in US and China being targeted
    Compumedic hits record medtech diagnostics revenue with growth in US and China being targeted
    • News

  • Lumos Diagnostics expands FebriDx distribution to Belgium
    Lumos Diagnostics expands FebriDx distribution to Belgium
    • News

  • ASX IPO May: Intelicare
    • News

    ASX IPO May: Intelicare

    For the second consecutive month, only one company is set to list in May, indicating that companies are still feeling reluctant to even attempt a public debut in the current economic environment.  Artificial intelligence (AI) tech company, Intelicare (Proposed ASX: ICR), is looking to raise a modest $5.5m at an offer price of $0.20. Intelicare

    Read More
    Public
  • Testing confirms EcoGraf can purify low value graphite for li-ion battery use
    • News

    Testing confirms EcoGraf can purify low value graphite for li-ion battery use

    The world may not have enough spherical graphite to meet demand for the growing lithium-ion battery market, but we may not need it with testing confirming that EcoGraf (ASX: EGR) can produce high purity graphite from low value by-products.  The EcoGraf(™) Process has been undergoing rigorous testing in Europe over the past 18 months with

    Read More
    Public
  • Top podiatry operator Healthia, makes big push in Victoria with 12 clinic acquisition
    • News

    Top podiatry operator Healthia, makes big push in Victoria with 12 clinic acquisition

    Allied health services group Healthia (ASX: HLA) has continued its expansion as Australia’s largest operator podiatry clinics, today announcing the acquisition of 12 clinics in Victoria to significantly expand its healthcare offerings in the State.  Secured for a total consideration of $5 million, the 12 new clinics are forecast to deliver Healthia with $4.4m revenue

    Read More
    Public
  • Foxtel value plummets as News Corp and Telstra log 40% asset write-offs
    • News

    Foxtel value plummets as News Corp and Telstra log 40% asset write-offs

    As a flagship business within what has become one of the 21st century’s most competitive markets, Foxtel’s fight for survival may be nearing the end after owners News Corp (ASX: NWS) and Telstra (ASX:TLS) announced 40% write-offs in the value of the video subscription business.  65% owned by News Corp and 35% by Telstra, Foxtel

    Read More
    Public
  • Online sales up 80% through COVID-19 as Mosaic to re-open retail stores
    • News

    Online sales up 80% through COVID-19 as Mosaic to re-open retail stores

    Popular fashion labels Noni B, Katies, Rockmans and Rivers will soon be re-opening their retail stores with parent company Mosaic Brands (ASX: MOZ) confirming they will undergo a progressive restart after closing their 1,400 stores in March due to coronavirus biosecurity.  Despite its store network’s closure over the past six weeks, Mosaic’s focus towards online

    Read More
    Public
  • Houston we Have secures first cross-sell AI contracts since strategic acquisition
    • News

    Houston we Have secures first cross-sell AI contracts since strategic acquisition

    Microcap AI and prescriptive analytics company Houston we Have (ASX: HWH) has hit the ground running since rebranding and expediting an entry into the healthcare AI sector.  Although the contracts are collectively only expected to add $130k of revenue to Houston, it opens up significant market opportunities which have been brought upon by their acquisition

    Read More
    Public
  • CardieX to integrate cardiovascular sensor into popular wearables
    • News

    CardieX to integrate cardiovascular sensor into popular wearables

    Having obtained milestone results from their wearables technology, CardieX (ASX: CDX) will advance their unique blood pressure sensor development kit which will allow device makers such as Garmin, Apple and Fitbit to accurately monitor a user’s cardiovascular health.  The technology is a combination of CardieX’s proprietary algorithm and a photoplethysmogram (PPG) sensor which can detect

    Read More
    Public
  • Archer partners with IBM to advance quantum computing, shares surge 105%
    • News

    Archer partners with IBM to advance quantum computing, shares surge 105%

    Australian tech company Archer Materials (ASX: AXE) has secured one of the most high-profile of partners in IBM (NYSE: IBM) to advance the development of its world-first quantum computing processor chip that can operate at room temperature.  The partnership is a game changer for Archer, which will see its Sydney-based team collaborate with the IBM

    Read More
    Public
  • Bod receives first medicinal cannabis prescriptions in the UK
    • News

    Bod receives first medicinal cannabis prescriptions in the UK

    Cannabis healthcare company Bod Australia (ASX: BDA) has commenced its penetration of the lucrative UK medicinal cannabis market having received its first international prescriptions for their MediCabilis™ product.  With more than 7.3 million consumers of cannabis products in the UK annually, it represents a major addressable market for Bod which estimates its value to be

    Read More
    Public
  • HR tech booming as Xref automated reference tech sales surge
    • News

    HR tech booming as Xref automated reference tech sales surge

    Gone may be the days of awkward reference checking over the phone if the record sales by HR tech company Xref (ASX: XF1) are a sign of future recruiting practices, especially once hiring resumes after coronavirus protocols are lifted. Despite the global economic downturn brought upon by the coronavirus pandemic which has led to unemployment

    Read More
    Public
  • «
  • ‹
  • 292
  • 293
  • 294
  • 295
  • 296
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.